Pascal and Francis Bibliographic Databases


Search results

Your search



A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 262962

  • Page / 10519

Selection :

  • and

Walking the drug regulatory tightropeDOVE, Alan.Nature biotechnology. 2003, Vol 21, Num 5, pp 495-498, issn 1087-0156, 4 p.Article

Drug interaction. 2. How drugs interactHARTSHORN, Edward A.The Annals of pharmacotherapy. 2006, Vol 40, Num 3, pp 542-549, issn 1060-0280, 8 p.Article

Drug safety, drug quality, drug analysisGÖRÖG, Sandor.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 2, pp 247-253, issn 0731-7085, 7 p.Conference Paper

The Food and Drug Administration's Drug Safety Oversight Board: An Evolving Paradigm for Clinical Input on Drug SafetyTopicsGRANDINETTI, C. A; OSBORNE, S. F.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 2, pp 269-274, issn 0009-9236, 6 p.Article

Mesoporous silica material TUD-1 as a drug delivery systemHEIKKILÄ, T; SALONEN, J; HIRVONEN, J et al.International journal of pharmaceutics. 2007, Vol 331, Num 1, pp 133-138, issn 0378-5173, 6 p.Article

Metabolic drug interactionsMINERS, J. O.Current therapeutics. 1992, Vol 33, Num 10, pp 71-74, issn 0311-905XArticle

Drug repositioning for orphan diseasesSARDANA, Divya; CHENG ZHU; MINLU ZHANG et al.Briefings in bioinformatics. 2011, Vol 12, Num 4, pp 346-356, issn 1467-5463, 11 p.Article

A search for interaction among combinations of drugs of abuse and the use of isobolographic analysisTALLARIDA, R. J; MIDIC, U; LAMARRE, N. S et al.Journal of clinical pharmacy and therapeutics (Print). 2013, Vol 38, Num 3, pp 190-195, issn 0269-4727, 6 p.Article

Knowledge of food and drug administration reportable deviationsLAM, Rebecca; BRYANT, Barbara J.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 7, pp 1619-1623, issn 0041-1132, 5 p., 2Article

US food and drug administration pushed to changeMCCARTY, Michael.Lancet (British edition). 2006, Vol 367, Num 9523, issn 0140-6736, 1630,1643-1644 [3 p.]Article

La DroguePELICIER, Yves; THUILLIER, Guy.1992, 127 p., isbn 2-130-44843-7Book

SCALES AND BLINKERS, MOTES AND BEAMS: WHOSE VIEW IS OBSTRUCTED ON DRUG SCHEDULING?ROOM, Robin.Addiction (Abingdon. Print). 2011, Vol 106, Num 11, pp 1895-1896, issn 0965-2140, 2 p.Article

Imputation médicament par médicament en pharmacovigilance. Essai de comparaison des différentes méthodes = Assessment of adverse drug reactions in individual treatment: comparison of methodsLAGIER, G; VINCENS, M; LEFEBURE, B et al.Thérapie (Paris). 1983, Vol 38, Num 3, pp 295-302, issn 0040-5957Article

FDA Perspective on Companion Diagnostics: An Evolving Paradigm : PRECISION MEDICINEMANSFIELD, Elizabeth A.Clinical cancer research (Print). 2014, Vol 20, Num 6, pp 1453-1457, issn 1078-0432, 5 p.Article

Why the FDA can't protect the publicLENZER, Jeanne; BROWNLEE, Shannon.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7780, pp 966-968, issn 1759-2151, 3 p.Article

Razlike medu ovisnicima delinkventima s obzirom na direktnu i indirektnu involviranost u kriminalitet vezan uz drogu = Differences between the delinquent addicts in relation with direct and indirect involvement in the drugs related criminality = Différences entre les toxicomanes délinquants en relation avec une implication directe ou indirecte dans la criminalité liée à la drogueBUTORAC, Ksenija; TODOROVIC, Ljiljana Miksaj.Kriminologija & socijalna integracija. 2002, Vol 10, Num 1, pp 35-47, issn 1330-2604, 13 p.Article

Molybdenum hydroxylases as drug-metabolizing enzymesBEEDHAM, C; DAMANI, L. A.Drug metabolism reviews (Softcover ed.). 1985, Vol 16, Num 1-2, pp 119-156, issn 0360-2532Article

The role of the U.S. Food and Drug Administration in device evaluation and monitoringGastrointestinal endoscopy (Print). 2010, Vol 72, Num 1, pp 5-10, issn 0016-5107, 6 p.Article

The New Food and Drug Administration Drug Package Insert : Implications for Patient Safety and Clinical CareTEED WATSON, Kelley; BARASH, Paul G.Anesthesia and analgesia. 2009, Vol 108, Num 1, pp 211-218, issn 0003-2999, 8 p.Article

New antimicrobial agents approved by the U.S. food and drug administration in 2006 and new indications for previously approved agentsAntimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, issn 0066-4804, 2649Article

Recalls of spices due to bacterial contamination monitored by the U.S. food and drug administration : The predominance of salmonellaeVIJ, Vibha; AILES, Elizabeth; WOLYNIAK, Cecilia et al.Journal of food protection. 2006, Vol 69, Num 1, pp 233-237, issn 0362-028X, 5 p.Article

Trials and tribulations: A primer on successfully navigating the waters of the food and drug administrationFEINSOD, Matt; CHAMBERS, Wiley A.Ophthalmology (Rochester, MN). 2004, Vol 111, Num 10, pp 1801-1806, issn 0161-6420, 6 p.Article

Role of the Food and drug Administration in the use of molecular techniques in immunohematologyKOCHMAN, Sheryl A.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 1S, issn 0041-1132, 3S-9S, SUPConference Paper

A food and drug administration primer : Drug evaluation in the United States, Canada, and the European UnionSIMON, Lee S.Arthritis care and research. 2006, Vol 55, Num 1, pp 4-8, issn 0893-7524, 5 p.Article

Regulating Off-Label Drug Use : Rethinking the Role of the FDASTAFFORD, Randall S.The New England journal of medicine. 2008, Vol 358, Num 14, pp 1427-1429, issn 0028-4793, 3 p.Article

  • Page / 10519